← Leaderboards
Roger Joseph Hajjar
Massachusetts General Hospital
$8,017,519
Attributed
$8,017,519
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–07$2M$1.5M$1M$500K$0
'05
'06
'07
Funding mix
By agency
NIH$8,017,519 · 9
By mechanism
R01$7,838,368 · 6
K08$119,151 · 1
R13$60,000 · 2
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Rafael Meza$13,336,497
- Robert A Levine$14,709,794
- Calum A. Macrae$21,291,852
- Nicholas E. Houstis$1,672,002
- Donald M Lloyd-Jones$56,341,838
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureTransfectionGene TherapyAdenoviridaeLaboratory RatSarcoplasmic ReticulumEnzyme ActivityHypertrophyTransfection /Expression VectorPhospholambanCalcium FluxCalcium Transporting AtpaseClinical ResearchHuman TissueEchocardiographyHeartCardiac MyocytesNonhuman Therapy EvaluationBiotechnologyNuclear Magnetic Resonance SpectroscopyHeart VentricleCardiacMyocardiumMyocytes, Cardiac
Grant awards (26)
Optical & MRI Imaging of Stem Cells in Diseased Hearts$625,477
R01 · FY2007 · HL · contact PI
Genetic Editing of Ca Cycling in Diabetic Cardiomyopathy$423,750
R01 · FY2007 · HL · contact PI
PICOT and Cardiac Hypertrophy$411,461
R01 · FY2007 · HL · contact PI
Targeting Calcium Cycling in a Pre-Clinical Model of Cardiac Dysfunction$337,902
R01 · FY2007 · HL · contact PI
Cardiovascular Cell and Gene Therapy Conference III$10,000
R13 · FY2007 · HL · contact PI
Optical & MRI Imaging of Stem Cells in Diseased Hearts$656,495
R01 · FY2006 · HL · contact PI
PICOT and Cardiac Hypertrophy$406,188
R01 · FY2006 · HL · contact PI
K and Ca Channels in Cardiac Hypertrophy and Failure$387,481
R01 · FY2006 · HL · contact PI
Targeting Calcium Cycling in Pre-Clinical Model Cardiac$347,994
R01 · FY2006 · HL · contact PI
Cardiovascular Cell and Gene Therapy Conference III$10,000
R13 · FY2006 · HL · contact PI
Optical &MRI Imaging of Stem Cells in Diseased Hearts$672,294
R01 · FY2005 · HL
Adenoviral Gene Transfer of Ca2+ ATPase in Heart Failure$432,500
R01 · FY2005 · HL
K and Ca Channels in Cardiac Hypertrophy and Failure$396,806
R01 · FY2005 · HL
Cardiovascular Cell and Gene Therapy Conference III$10,000
R13 · FY2005 · HL
Optical &MRI Imaging of Stem Cells in Diseased Hearts$684,333
R01 · FY2004 · HL
Adenoviral Gene Transfer of Ca2+ ATPase in Heart Failure$484,400
R01 · FY2004 · HL
K and Ca Channels in Cardiac Hypertrophy and Failure$396,806
R01 · FY2004 · HL
Cardiovascular Cell and Gene Therapy Conference$10,000
R13 · FY2004 · HL
Adenoviral Gene Transfer of Ca2+ ATPase in Heart Failure$9,802
R01 · FY2004 · HL
K and Ca Channels in Cardiac Hypertrophy and Failure$396,806
R01 · FY2003 · HL
Adenoviral Gene Transfer of Ca2+ ATPase in Heart Failure$301,956
R01 · FY2003 · HL
Cardiovascular Cell and Gene Therapy Conference$10,000
R13 · FY2003 · HL
Adenoviral Gene Transfer of Ca2+ ATPase in Heart Failure$432,500
R01 · FY2002 · HL
Cardiovascular Cell and Gene Therapy Conference$10,000
R13 · FY2002 · HL
ADENOVIRAL GENE TRANSFER IN HEART FAILURE$119,151
K08 · FY2000 · HL
ADENOVIRAL GENE TRANSFER OF CA++ ATPASE IN HEART FAILURE$33,417
R01 · FY2000 · HL